SMLR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SMLR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-13), Semler Scientific's share price is $32.62. Semler Scientific's Book Value per Share for the quarter that ended in Dec. 2024 was $24.15. Hence, Semler Scientific's PB Ratio of today is 1.35.
Good Sign:
Semler Scientific Inc stock PB Ratio (=1.39) is close to 10-year low of 1.39
The historical rank and industry rank for Semler Scientific's PB Ratio or its related term are showing as below:
During the past 13 years, Semler Scientific's highest PB Ratio was 988.89. The lowest was 1.33. And the median was 13.60.
During the past 12 months, Semler Scientific's average Book Value Per Share Growth Rate was 131.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 53.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 54.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Semler Scientific was 116.60% per year. The lowest was 27.40% per year. And the median was 50.70% per year.
The historical data trend for Semler Scientific's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Semler Scientific Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
21.14 | 13.60 | 3.97 | 4.25 | 2.24 |
Semler Scientific Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
4.25 | 2.59 | 3.07 | 1.96 | 2.24 |
For the Medical Devices subindustry, Semler Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Semler Scientific's PB Ratio distribution charts can be found below:
* The bar in red indicates where Semler Scientific's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Semler Scientific's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Dec. 2024) |
= | 32.62 | / | 24.147 | |
= | 1.35 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Semler Scientific (NAS:SMLR) PB Ratio Explanation
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Semler Scientific's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Douglas Murphy-chutorian | director, 10 percent owner, officer: Chief Executive Officer | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
Eric Semler | director | 4625 FIELDSTON ROAD, BRONX NY 10471 |
Renae Cormier | officer: Chief Financial Officer | C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVE, SUITE 2344, SANTA CLARA CA 95051 |
Wayne T Pan | director | 2330 NW EVERETT STREET, PORTLAND OR 97210 |
William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006 | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 911 BERN CT., SAN JOSE CA 95112 |
Chang 2020 Delaware Lp | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, SUITE 2344, SANTA CLARA CA 95051 |
Arthur N Leibowitz | director | C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103 |
Chang 2020 Gp Llc | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, STE. 2344, SANTA CLARA CA 95051 |
Cindy Moon | director | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SAN JOSE CA 95112 |
Daniel S Messina | director | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, STE. 110, SAN JOSE Z4 95112 |
Daniel E Conger | officer: Vice President, Finance | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
William H Chang | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
Diana Shon Chang | 10 percent owner | 1301 SHOREWAY RD., SUITE 150, BELMONT CA 94002 |
Andrew B. Weinstein | officer: Senior VP, Finance and Acct. | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
Herbert J Semler | director, 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST., PORTLAND OR 97210 |
From GuruFocus
By PRNewswire • 01-23-2025
By GuruFocus News • 12-27-2024
By GuruFocus News • 02-04-2025
By GuruFocus News • 01-29-2025
By PRNewswire • 01-13-2025
By GuruFocus News • 01-17-2025
By PRNewswire • 11-18-2024
By PRNewswire • 02-04-2025
By GuruFocus News • 11-19-2024
By GuruFocus News • 01-08-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.